The measurement of carotid intima media thickness precisely and accurately for evaluating epilectic children treated with oxcarbazepine

Brain and Development

Volumn 35, Issue 7, 2013, Pages 694-

  Inci, Mehmet Fatih ^a   Ozkan, Fuat ^a   Demir, Caner Feyzi ^b  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; OXCARBAZEPINE; TRIACYLGLYCEROL;

ACOUSTICS; ANTICONVULSANT THERAPY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CLINICAL PRACTICE; ECHOGRAPHY; EPILEPSY; HUMAN; LETTER; PRACTICE GUIDELINE;

ANTICONVULSANTS; CARBAMAZEPINE; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; HUMANS; LIPIDS;

EID: 84879464341     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2013.01.014     Document Type: Letter

References (5)

1. Yiş U., Doǧan M. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. Brain Dev 2012, 34:185-188.
2. Davis P.H., Dawson J.D., Blecha M.B., Mastbergen R.K., Sonka M. Measurement of aortic intimal-medial thickness in adolescents and young adults. Ultrasound Med Biol 2010, 36:560-565.
3. Coll B., Feinstein S.B. Carotid intima-media thickness measurements: techniques and clinical relevance. Curr Atheroscler Rep 2008, 10:444-450.
4. Stein J.H., Korcarz C.E., Hurst R.T., Lonn E., Kendall C.B., Mohler E.R., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008, 21:93-111.
5. Chuang Y.C., Chuang H.Y., Lin T.K., Chang C.C., Lu C.H., Chang W.N., et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012, 53:120-128.